Odontoprev S.A. (BVMF:ODPV3)
Brazil
· Delayed Price · Currency is BRL 10.56
+0.14 (1.34%)
Apr 23, 2025, 4:45 PM GMT-3
Odontoprev Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Premiums & Annuity Revenue | 2,243 | 2,084 | 1,847 | 1,923 | 1,848 | Upgrade
|
| Total Interest & Dividend Income | 133.47 | 126.19 | 88.84 | 54.28 | 21.08 | Upgrade
|
| Non-Insurance Activities Revenue | 52.67 | 51.56 | 21.89 | 16.41 | 13.45 | Upgrade
|
| Total Revenue | 2,429 | 2,261 | 1,958 | 1,994 | 1,883 | Upgrade
|
| Revenue Growth (YoY) | 7.41% | 15.50% | -1.79% | 5.91% | -1.97% | Upgrade
|
| Policy Benefits | 757.25 | 737.85 | 735.47 | 700.38 | 661.48 | Upgrade
|
| Policy Acquisition & Underwriting Costs | 268.3 | 242.59 | 245.26 | - | - | Upgrade
|
| Depreciation & Amortization | 3.96 | 4.32 | 2.07 | 5.82 | 5.11 | Upgrade
|
| Selling, General & Administrative | 102.17 | 99.28 | 30.71 | 516.53 | 470 | Upgrade
|
| Provision for Bad Debts | 6.37 | 0.9 | 0.88 | 48.92 | 48.66 | Upgrade
|
| Other Operating Expenses | 439.89 | 370.94 | 347.58 | 123.77 | 143.16 | Upgrade
|
| Total Operating Expenses | 1,614 | 1,491 | 1,389 | 1,437 | 1,353 | Upgrade
|
| Operating Income | 815.24 | 770.07 | 568.98 | 556.8 | 529.13 | Upgrade
|
| Interest Expense | -36.46 | -33.55 | -6.08 | -2.7 | -2.82 | Upgrade
|
| Earnings From Equity Investments | 6.34 | 4.15 | 6.13 | 6.56 | 6.67 | Upgrade
|
| Other Non Operating Income (Expenses) | -20.87 | -14.3 | -45.09 | -12.36 | -13.11 | Upgrade
|
| EBT Excluding Unusual Items | 764.26 | 726.37 | 523.94 | 548.3 | 519.87 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.88 | -1.98 | -6.64 | -1.12 | 0.14 | Upgrade
|
| Pretax Income | 763.38 | 724.39 | 517.29 | 547.18 | 520.01 | Upgrade
|
| Income Tax Expense | 224.24 | 212.8 | 151.05 | 165.84 | 160.29 | Upgrade
|
| Earnings From Continuing Ops. | 539.13 | 511.59 | 366.25 | 381.34 | 359.72 | Upgrade
|
| Minority Interest in Earnings | 0.11 | -0.2 | -0.39 | -0.98 | 1.41 | Upgrade
|
| Net Income | 539.24 | 511.39 | 365.86 | 380.36 | 361.13 | Upgrade
|
| Net Income to Common | 539.24 | 511.39 | 365.86 | 380.36 | 361.13 | Upgrade
|
| Net Income Growth | 5.45% | 39.78% | -3.81% | 5.33% | 26.82% | Upgrade
|
| Shares Outstanding (Basic) | 547 | 552 | 553 | 579 | 583 | Upgrade
|
| Shares Outstanding (Diluted) | 547 | 552 | 553 | 580 | 584 | Upgrade
|
| Shares Change (YoY) | -1.04% | -0.08% | -4.68% | -0.72% | -0.06% | Upgrade
|
| EPS (Basic) | 0.99 | 0.93 | 0.66 | 0.66 | 0.62 | Upgrade
|
| EPS (Diluted) | 0.99 | 0.93 | 0.66 | 0.66 | 0.62 | Upgrade
|
| EPS Growth | 6.55% | 39.89% | 0.91% | 6.08% | 26.89% | Upgrade
|
| Free Cash Flow | 594.44 | 406.96 | 686.19 | 852.87 | 295.34 | Upgrade
|
| Free Cash Flow Per Share | 1.09 | 0.74 | 1.24 | 1.47 | 0.51 | Upgrade
|
| Dividend Per Share | 0.665 | 0.928 | 0.433 | 0.327 | 0.571 | Upgrade
|
| Dividend Growth | -28.36% | 114.42% | 32.52% | -42.83% | 67.09% | Upgrade
|
| Operating Margin | 33.56% | 34.05% | 29.06% | 27.93% | 28.11% | Upgrade
|
| Profit Margin | 22.20% | 22.61% | 18.68% | 19.08% | 19.18% | Upgrade
|
| Free Cash Flow Margin | 24.47% | 18.00% | 35.04% | 42.78% | 15.69% | Upgrade
|
| EBITDA | 827.27 | 819.3 | 601.37 | 614.56 | 553.97 | Upgrade
|
| EBITDA Margin | 34.06% | 36.23% | 30.71% | 30.82% | 29.43% | Upgrade
|
| D&A For EBITDA | 12.03 | 49.23 | 32.4 | 57.76 | 24.85 | Upgrade
|
| EBIT | 815.24 | 770.07 | 568.98 | 556.8 | 529.13 | Upgrade
|
| EBIT Margin | 33.56% | 34.05% | 29.06% | 27.93% | 28.11% | Upgrade
|
| Effective Tax Rate | 29.38% | 29.38% | 29.20% | 30.31% | 30.82% | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.